Jarvik GP - Search Results

1

Discovery and replication of SNP-SNP interactions for quantitative lipid traits in over 60,000 individuals.

Holzinger ER, Verma SS, Moore CB, Hall M, De R, Gilbert-Diamond D, Lanktree MB, Pankratz N, Amuzu A, Burt A, Dale C, Dudek S, Furlong CE, Gaunt TR, Kim DS, Riess H, Sivapalaratnam S, Tragante V, van Iperen EPA, Brautbar A, Carrell DS, Crosslin DR, Jarvik GP, Kuivaniemi H, Kullo IJ, Larson EB, Rasmussen-Torvik LJ, Tromp G, Baumert J, Cruickshanks KJ, Farrall M, Hingorani AD, Hovingh GK, Kleber ME, Klein BE, Klein R, Koenig W, Lange LA, Mӓrz W, North KE, Charlotte Onland-Moret N, Reiner AP, Talmud PJ, van der Schouw YT, Wilson JG, Kivimaki M, Kumari M, Moore JH, Drenos F, Asselbergs FW, Keating BJ, Ritchie MD. Holzinger ER, et al. Among authors: jarvik gp. BioData Min. 2017 Jul 24;10:25. doi: 10.1186/s13040-017-0145-5. eCollection 2017. BioData Min. 2017. PMID: 28770004 Free PMC article.

2

Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study.

Jarvik GP, Wijsman EM, Kukull WA, Schellenberg GD, Yu C, Larson EB. Jarvik GP, et al. Neurology. 1995 Jun;45(6):1092-6. doi: 10.1212/wnl.45.6.1092. Neurology. 1995. PMID: 7783869

3

Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sample.

Jarvik G, Larson EB, Goddard K, Schellenberg GD, Wijsman EM. Jarvik G, et al. Am J Hum Genet. 1996 Jan;58(1):191-200. Am J Hum Genet. 1996. PMID: 8554056 Free PMC article.

4

Analysis of paraoxonase (PON1) L55M status requires both genotype and phenotype.

Brophy VH, Jarvik GP, Richter RJ, Rozek LS, Schellenberg GD, Furlong CE. Brophy VH, et al. Among authors: jarvik gp. Pharmacogenetics. 2000 Jul;10(5):453-60. doi: 10.1097/00008571-200007000-00008. Pharmacogenetics. 2000. PMID: 10898114

5

The PON1 gene and detoxication.

Furlong CE, Li WF, Brophy VH, Jarvik GP, Richter RJ, Shih DM, Lusis AJ, Costa LG. Furlong CE, et al. Among authors: jarvik gp. Neurotoxicology. 2000 Aug;21(4):581-7. Neurotoxicology. 2000. PMID: 11022865

6

Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype.

Jarvik GP, Rozek LS, Brophy VH, Hatsukami TS, Richter RJ, Schellenberg GD, Furlong CE. Jarvik GP, et al. Arterioscler Thromb Vasc Biol. 2000 Nov;20(11):2441-7. doi: 10.1161/01.atv.20.11.2441. Arterioscler Thromb Vasc Biol. 2000. PMID: 11073850

7

Polymorphisms in the human paraoxonase (PON1) promoter.

Brophy VH, Hastings MD, Clendenning JB, Richter RJ, Jarvik GP, Furlong CE. Brophy VH, et al. Among authors: jarvik gp. Pharmacogenetics. 2001 Feb;11(1):77-84. doi: 10.1097/00008571-200102000-00009. Pharmacogenetics. 2001. PMID: 11207034

8

Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression.

Brophy VH, Jampsa RL, Clendenning JB, McKinstry LA, Jarvik GP, Furlong CE. Brophy VH, et al. Among authors: jarvik gp. Am J Hum Genet. 2001 Jun;68(6):1428-36. doi: 10.1086/320600. Epub 2001 May 2. Am J Hum Genet. 2001. PMID: 11335891 Free PMC article.

9

Pharmacogenomic considerations of the paraoxonase polymorphisms.

Furlong CE, Cole TB, Jarvik GP, Costa LG. Furlong CE, et al. Among authors: jarvik gp. Pharmacogenomics. 2002 May;3(3):341-8. doi: 10.1517/14622416.3.3.341. Pharmacogenomics. 2002. PMID: 12052142 Review.

10

Vitamin C and E intake is associated with increased paraoxonase activity.

Jarvik GP, Tsai NT, McKinstry LA, Wani R, Brophy VH, Richter RJ, Schellenberg GD, Heagerty PJ, Hatsukami TS, Furlong CE. Jarvik GP, et al. Arterioscler Thromb Vasc Biol. 2002 Aug 1;22(8):1329-33. doi: 10.1161/01.atv.0000027101.40323.3a. Arterioscler Thromb Vasc Biol. 2002. PMID: 12171796

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

514 results

Search Page